Hepatitis B virus, also known as HBV or Orthohepadnavirus, is a type of virus that belongs to the Hepadnaviridae family of viruses. Hepatitis B is brought on by the virus HBV. The ground squirrel hepatitis virus, the woodchuck hepatitis virus, and the woolly monkey hepatitis B virus are the other three species that make up the Orthohepadnavirus, of which the hepatitis B virus is the type species. The Hepadnaviridae family includes the genus as a member. Based on antigenic epitopes found on its envelope proteins, HBV is classified into four major serotypes (adr, adw, ayr, ayw), and eight genotypes (A-H) based on the genome's overall nucleotide sequence variation.The genotypes are used to track the evolution and spread of the virus because they have a distinct geographic distribution. The severity of the disease, the progression and propensity for complications, the response to treatment, and perhaps vaccination, are all impacted by genotype differences.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V3511 | Entecavir (SQ 34676) | 142217-69-4 | Entecavir (Baraclude;SQ34676 and BMS200475), anti-hepatitis B virus (HBV) agent,is a novel deoxyguanine nucleoside analogue and areverse transcriptase inhibitor. |
|
V54190 | Exbivirumab | 569658-80-6 | Exbivirumab is an anti-HBV (hepatitis B virus) monoclonal antibody (mAb). |
|
V54174 | Firzacorvir | 2243747-96-6 | Firzacorvir is a cyclic sulfonamide compound that modulates HBV (hepatitis B virus) core protein. |
|
V54208 | Glycosmisic acid | 443908-19-8 | Glycosmisic acid is a naturally occurring compound with anti-HBV (hepatitis B virus) activity. |
|
V52028 | GST-HG131 | 2270215-69-3 | GST-HG131 is a specific HBV (hepatitis B virus) surface antigen inhibitor and belongs to the dihydrobenzopyridoxal (DBP) class of compounds. |
|
V54195 | HBV Seq1 aa:141-151 | 147318-53-4 | HBV (hepatitis B virus) Seq1 aa:141-151 is a bioactive peptide. |
|
V54196 | HBV Seq1 aa:18-27 | 147820-47-1 | HBV (hepatitis B virus) Seq1 aa:18-27 is the peptide fragment of HBV (hepatitis B virus) core antigen 18-27. |
|
V54186 | HBV Seq1 aa:63-71 | 189323-64-6 | HBV (hepatitis B virus) Seq1 aa:63-71 is a fragment of HBV (hepatitis B virus). |
|
V77804 | HBV Seq1 aa:93-100 | HBV (hepatitis B virus) Seq1 aa:93-100 is the peptide fragment of HBV (hepatitis B virus) core antigen 93-100. | |
|
V52011 | HBV Seq2 aa:208-216 | 160214-63-1 | HBV (hepatitis B virus) Seq2 aa:208-216 is an HBsAg-derived CD8 epitope peptide studied as part of the hepatitis B virus large envelope protein. |
|
V52010 | HBV Seq2 aa:28-39 | 168417-72-9 | HBV (hepatitis B virus) Seq2 aa:28-39 is an HBsAg peptide that binds to major histocompatibility complex (MHC) class I molecules. |
|
V54202 | HBV-IN-10 | 2716907-16-1 | HBV (hepatitis B virus)-IN-10 is an isomer of compound 6 (WO2021204258A1). |
|
V54193 | HBV-IN-11 | 2226178-41-0 | HBV (hepatitis B virus)-IN-11 (Example 28) is a potent inhibitor of HBsAg secretion with EC50 of 0.46 µM (for details, check and find WO2018085619A1, example 28). |
|
V54177 | HBV-IN-12 | 2724229-06-3 | HBV (hepatitis B virus)-IN-12 is a potent inhibitor of hepatitis B surface antigen (HBsAg) (0.001 μM< EC50 ≤0.05 μM). |
|
V54205 | HBV-IN-13 | 2724228-72-0 | HBV (hepatitis B virus)-IN-12 is a potent inhibitor of hepatitis B surface antigen (HBsAg). |
|
V52009 | HBV-IN-29 | 2413192-59-1 | HBV (hepatitis B virus)-IN-29 (ex8) is a flavonoid analogue and a potent inhibitor of covalently closed circular DNA (cccDNA). |
|
V52008 | HBV-IN-30 | 2413192-92-2 | HBV (hepatitis B virus)-IN-30 (ex44) is a flavonoid analogue and a potent inhibitor of covalently closed circular DNA (cccDNA). |
|
V52007 | HBV-IN-31 | 2413192-95-5 | HBV (hepatitis B virus)-IN-31 is a potent inhibitor of covalently closed circular DNA (cccDNA). |
|
V52006 | HBV-IN-32 | 2413193-04-9 | HBV (hepatitis B virus)-IN-31 is a potent inhibitor of covalently closed circular DNA (cccDNA). |
|
V79034 | HBV-IN-33 | HBV (hepatitis B virus)-IN-33 (C-49) is an inhibitor (blocker/antagonist) of HBV (hepatitis B virus) and significantly inhibits HBV (hepatitis B virus) replication in HepAD38, HepG2-HBV (hepatitis B virus)1.3 and HepG2-NTCP cells. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
